{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:37:37Z","timestamp":1790415457620,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bcp.2018.07.042","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T22:22:14Z","timestamp":1533075734000},"page":"189-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination"],"prefix":"10.1016","volume":"157","author":[{"given":"Andrea","family":"Manterola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bernal-Chico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaela","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Canedo-Antelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Mart\u00edn-Fontecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"P\u00e9rez-Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ortega-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ku-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.07.042_b0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2018.07.042_b0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.042_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bpa.12454","article-title":"Multiple sclerosis animal models: a clinical and histopathological perspective","volume":"27","author":"Kipp","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bcp.2018.07.042_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0304-3940(02)00209-4","article-title":"Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10","volume":"324","author":"Molina-Holgado","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2018.07.042_b0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcp.2018.07.042_b0030","first-page":"1585","article-title":"De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected","volume":"26","author":"Skripuletz","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bcp.2018.07.042_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases","volume":"160","author":"Chiurchi\u00f9","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2018.07.042_b0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in a multiple sclerosis model","volume":"15","author":"Baker","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2018.07.042_b0050","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2018.07.042_b0055","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1096\/fj.04-2464fje","article-title":"Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis","volume":"19","author":"Ortega-Guti\u00e9rrez","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2018.07.042_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.22742","article-title":"Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo","volume":"63","author":"Bernal-Chico","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0065","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1523\/JNEUROSCI.2900-16.2017","article-title":"2-Arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination","volume":"37","author":"Feli\u00fa","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0070","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drudis.2013.07.009","article-title":"Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy","volume":"19","author":"Alhouayek","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2018.07.042_b0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2015.07.010","article-title":"Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis","volume":"99","author":"Wen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2018.07.042_b0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuron.2014.06.030","article-title":"ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6\/2 mice","volume":"83","author":"Naydenov","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2018.07.042_b0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/neu.2012.2647","article-title":"Selective inhibition of alpha\/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury","volume":"30","author":"Tchantchou","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2018.07.042_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","article-title":"Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide","volume":"28","author":"Lor\u00eda","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0105","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1073\/pnas.0510418103","article-title":"Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection","volume":"103","author":"Witting","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2018.07.042_b0110","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/brain\/awm160","article-title":"The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis","volume":"130","author":"Centonze","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2018.07.042_b0115","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1021\/jm400899c","article-title":"Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of \u03b1\/\u03b2-hydrolase domain containing 6 (ABHD6)","volume":"56","author":"Hsu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.07.042_b0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.celrep.2013.08.047","article-title":"The serine hydrolase ABHD6 is a critical regulator of the metabolic syndrome","volume":"5","author":"Thomas","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2018.07.042_b0125","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2012"},{"key":"10.1016\/j.bcp.2018.07.042_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002554","article-title":"Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis\/microglial phagocytosis uncoupling","volume":"14","author":"Abiega","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2018.07.042_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116644","article-title":"Glioma-associated microglia\/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1","volume":"10","author":"Szulzewsky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.07.042_b0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcp.2018.07.042_b0145","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.1118167109","article-title":"Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors","volume":"109","author":"den Boon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2018.07.042_b0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1083\/jcb.85.3.890","article-title":"Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue","volume":"85","author":"McCarthy","year":"1980","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2018.07.042_b0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/glia.20221","article-title":"Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition","volume":"52","author":"Domercq","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0160","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2018.07.042_b0165","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hern\u00e1ndez-Torres","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bcp.2018.07.042_b0170","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/glia.21061","article-title":"The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation","volume":"58","author":"Gomez","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-017-1045-9","article-title":"WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms","volume":"15","author":"Wen","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2018.07.042_b0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.07.042_b0185","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.23-07-02511.2003","article-title":"Therapeutic action of cannabinoids in a murine model of multiple sclerosis","volume":"23","author":"Ar\u00e9valo-Mart\u00edn","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0190","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","article-title":"Cannabinoids inhibit neurodegeneration in models of multiple sclerosis","volume":"126","author":"Pryce","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2018.07.042_b0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2018.07.042_b0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/glia.22773","article-title":"Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors","volume":"63","author":"Metna-Laurent","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2018.07.042_b0210","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2353\/ajpath.2007.060783","article-title":"Microglial recruitment, activation, and proliferation in response to primary demyelination","volume":"170","author":"Remington","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2018.07.042_b0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2018.07.042_b0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2018.07.042_b0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jns.2009.07.021","article-title":"Plasma endocannabinoid levels in multiple sclerosis","volume":"287","author":"Jean-Gilles","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bcp.2018.07.042_b0230","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/jnnp.2007.139071","article-title":"Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis","volume":"79","author":"Di Filippo","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bcp.2018.07.042_b0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","article-title":"Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis","volume":"20","author":"Cabranes","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2018.07.042_b0240","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.12152","article-title":"Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways","volume":"280","author":"Ueda","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2018.07.042_b0245","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4814-06.2007","article-title":"Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis","volume":"27","author":"Benito","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.plefa.2011.04.001","article-title":"Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination","volume":"85","author":"Palumbo","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bcp.2018.07.042_b0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE\u2082 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2018.07.042_b0260","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcp.2018.07.042_b0265","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2015.06.075","article-title":"Metabolic Interplay between astrocytes and neurons regulates endocannabinoid action","volume":"12","author":"Viader","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2018.07.042_b0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.1075","article-title":"Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis","volume":"41","author":"Berrendero","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2018.07.042_b0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2006.06.001","article-title":"Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice","volume":"1107","author":"Cabranes","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2018.07.042_b0280","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1074\/jbc.M707960200","article-title":"The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis","volume":"283","author":"Palazuelos","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.07.042_b0285","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fnins.2016.00406","article-title":"Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders","volume":"10","author":"Navarro","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.042_b0290","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.celrep.2017.11.058","article-title":"Diverging mRNA and protein networks in activated microglia reveal SRSF3 suppresses translation of highly upregulated innate immune transcripts","volume":"21","author":"Boutej","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2018.07.042_b0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2018.07.042_b0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain Behav. Immun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T12:47:39Z","timestamp":1543927659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218303113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":60,"alternative-id":["S0006295218303113"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.042","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}